Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Galecto, Inc.
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
March 9, 2026
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 4, 2026
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
March 2, 2026
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million
February 12, 2026
Galecto Announces Pricing of $275 Million Underwritten Public Offering
February 10, 2026
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
February 10, 2026